OLYMPUS (OLY1 MU) stock market data APIs
€8.1794
0.01(0.1%)
as of March 31, 2026
Try our APIs with
free plan!
OLYMPUS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for OLY1.MU.
Prev. Close
8.1794
Open
8.1868
High
8.1868
Low
8.1479
52 wk Range
6.9269-12.2505
Market Cap
24 510 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get OLYMPUS data using free add-ons & libraries
Get OLYMPUS Fundamental Data
OLYMPUS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
OLYMPUS News
New
Disposable Endoscope Analysis Report 2025: A $4.95 Billion Market by 2029 - Aging Population and Growing Healthcare Expenditure Accelerate Shift Toward Disposable Endoscopic Solutions
Company Logo The global disposable endoscope market, valued at US$1.89 billion in 2023, is projected to reach US$4.95 billion by 2029, driven by rising hospital-acquired infections and demand for saf...
EAGLE Trial Shows Olympus(R) CADDIE(TM) AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions
Cloud-based AI Application for Colorectal Cancer Prevention: Enhancing Detection of Clinically Significant Lesions Without Compromising Safety and Workflow Efficiency TOKYO, JAPAN - February 3, 2026 ...
Should Olympus’ PolyLoop Recall and VIABIL Deal Reshape the Medtech Story for Olympus (TSE:7733) Investors?
In December 2025, Olympus Corporation announced a voluntary corrective action for its Single-Use Ligating Device (“PolyLoop”) after reports that the device could fail to release as intended, poten...
Olympus, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States
CENTER VALLEY, Pa., Dec. 5, 2025 /PRNewswire/ -- Olympus Corporation ("Olympus"), W. L. Gore & Associates, Inc. ("Gore"), and ConMed Corporation ("ConMed") jointly announced today the upcoming transi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
